이 누리집은 대한민국 공식 전자정부 누리집입니다.
Biz News Korea(Eng)
Retail investors file damage suits vs Hanmi Pharm, criminal actions could follow
- Collected
- 2016.10.22
- Distributed
- 2016.10.24
- Source
- Go Direct
According to sources from the industry on Friday, the retail investors filed a civil lawsuit against the drug maker for damages with the Seoul Central District Court. They demanded a combined 2.46 billion won ($2.1 million) in compensation but the amount can multiply as the plaintiff usually keeps the damage amount to a minimum at the early stages of the suit. Moreover, retail investors are expected to file criminal and class legal actions against the pharmaceutical company depending on the probe findings of the Financial Supervisory Service and prosecution.
Yoon Je-sun, a plaintiff’s attorney from law firm Jeha said the litigation could get bigger as there are more retail investors willing to join. "A criminal or class-action lawsuit would be possible depending on the ongoing investigations by the FSC and prosecution," he added.
The plaintiffs reportedly included at least two lawyers and an accountant, suggesting that financial experts who should have more information on the stock market than lay people have also been burned by the alleged breach of trust from the company.
By Yoo Tae-yang
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]